Invobenitug
英沃茵塔单抗
Report date: 2026/04/24 20:01:59
Base Information
Drug NameInvobenitug
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies4TEEN4 Pharmaceuticals GmbH
China Registration ClassN/A
Develop Information
Active Companies4TEEN4 Pharmaceuticals GmbH
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A